Renal Denervation Market, by Product Type (Simplicity Renal Denervation System, Enlightn, Vessix Renal Denervation System, Paradise Renal Denervation System, Iberis Renal Sympathetic Denervation System), Technology Type (Radiofrequency, Ultrasound, Micro-Infusion, Pharmacologic), End-User Type (Hospitals, Specialty Clinics, Research and Academic Institutes, Ambulatory Care Centers), and Region (North America [The USA, Canada, and Mexico], Europe [Germany, France, The UK, Italy, Spain and Rest of Europe], Asia-Pacific [China, Japan, India, South Korea, and Rest of Asia-Pacific], Middle East & Africa and South America).
Market Insights
The renal denervation market is expected to grow at a CAGR of 31.6% during the forecast period. The market was valued at US$ 600.0 million in 2021 and will reach US$ 5,396.4 million by 2028.
Renal denervation is a minimally invasive catheter-based treatment that is used to treat resistant hypertension. In the process, radiofrequency ablation is used to burn nerves in the renal arteries. If pharmacological treatment does not result in relief, this procedure is usually used to achieve better results. The nerves in the renal artery wall are removed using high-frequency pulses or ultrasound.
It lowers blood pressure by reducing the activity of the sympathetic kidneys. The market growth is challenged by the risk associated with post-surgery infection, the high cost of renal denervation techniques, the lack of skilled workforce, changes in renal anatomy and long term follow-up procedures.Top of Form
Custom Research: Stratview Research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.
